abbreviation
- EXP DERMATOL
EXPERIMENTAL DERMATOLOGY
Journal
Overview
publication venue for
- Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study. 33. 2024
- Long-term skin regeneration in xenografts from iPSC teratoma-derived human keratinocytes. 25:736-738. 2016
-
A non-viral gene
therapy for treatment of recessive dystrophic epidermolysis bullosa. 25:818-820. 2016 - Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia. 25:269-274. 2016
- Tumor initiation by skin Ha-ras-ment. 24:252-253. 2015
- Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies. 23:199-201. 2014
- Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen. 23:130-132. 2014
- Keratinocyte cell lines derived from severe generalized recessive Epidermolysis Bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo. 22:601-603. 2013
- The regenerative potential of fibroblasts in a new diabetes-induced delayed humanised wound healing model. 22:195-201. 2013
International Standard Serial Number (ISSN)
- 0906-6705
Electronic International Standard Serial Number (EISSN)
- 1600-0625